Gabriele Cerrone

Gabriele Marco Antonio Cerrone was the founder of Tiziana Life Sciences Ltd. (United Kingdom) founded in 1998, holding the titles Executive Chairman & Chief Executive Officer; Tiziana Life Sciences Ltd. (Bermuda) founded in 1998, holding the title Executive Chairman; Cardiff Oncology, Inc. founded in 1999, holding the title Co-Chairman in 2006; FermaVir Pharmaceuticals LLC founded in 2004, holding the title Chairman from 2004 to 2007; Synergy Pharmaceuticals LLC founded in 2008, holding the title Chairman; Rasna Therapeutics, Inc. founded in 2013, holding the title Chairman; AccuStem Sciences, Inc. founded in 2020, holding the title Non-Executive Chairman since 2021.
Mr. Cerrone is also the founder of Hepion Pharmaceuticals, Inc.,Arna Therapeutics Ltd.,Biovitas Capital Ltd.,Gensignia Life Sciences, Inc.,Gensignia Ltd...
Current positions include Executive Chairman & Managing Partner at Panetta Partners Ltd. since 2013; Non-Executive Chairman at OKYO Pharma Ltd. since 2021; Director at Gensignia IP Ltd. since 2014.
Former positions include Chairman at Callisto Pharmaceuticals, Inc. from 2003 to 2013; Director at SIGA Technologies, Inc. in 2003; Independent Director at Inhibitex LLC from 2011 to 2012; Director at Pawfect Foods, Inc.; Managing Director-Investments at Barrington Capital Group LP in 1999; Senior Vice President-Investments at Oppenheimer & Co., Inc. from 1999 to 2005.
Education includes an MBA from The Leonard N Stern School of Business.